Intravenous Immunoglobulin Initiation in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A US Claims-based Cohort Study

Abstract Introduction Intravenous immunoglobulin (IVIG) is recommended as first-line therapy for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), an immune-mediated neuropathy. The clinical profile of patients with CIDP newly initiating IVIG is poorly characterized. This claims-base...

Full description

Bibliographic Details

Published in:	Neurology and Therapy
Main Authors:	J. Bradley Layton, Mary E. Ritchey, Zhongwen Huang, Shailesh Chavan, Hakan Ay, Nizar Souayah, Colin Anderson-Smits
Format:	Article
Language:	English
Published:	Adis, Springer Healthcare 2023-05-01
Subjects:	Chronic inflammatory demyelinating polyradiculoneuropathy Intravenous immunoglobulin Claims database
Online Access:	https://doi.org/10.1007/s40120-023-00479-4